GlassScriptPhysician profile
Diane E Hattel
NPI 1003951229
$1,957.18
in general payments reported to CMS, 2019-2025
21 companies · $203 in 2025
The $203 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $573 · 2022: $607 · 2023: $405 · 2024: $169 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $777.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $443.50 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $266.23 | 2021-2025 | Mounjaro, Zepbound, Kisunla |
| Supernus Pharmaceuticals, INC. | $203.55 | 2021-2023 | Qelbree |
| Abbvie INC. | $175.41 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $174.53 | 2021-2023 | Jardiance |
| Novo Nordisk INC | $124.57 | 2021-2025 | Rybelsus, Ozempic, Saxenda |
| Merck Sharp & Dohme LLC | $93.81 | 2021 | |
| Pfizer INC. | $70.59 | 2021-2023 | |
| Exact Sciences Corporation | $63.98 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $50.77 | 2022 | |
| Paratek Pharmaceuticals, INC. | $45.77 | 2021-2022 | |
| Ultragenyx Pharmaceutical INC. | $41.48 | 2021 | |
| Corium, LLC | $31.16 | 2022-2023 | Azstarys |
| Eisai INC. | $30.66 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.52 | 2023-2025 | Xifaxan, Trulance |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $27.24 | 2021 | |
| Nestle Healthcare Nutrition INC. | $23.80 | 2022 | |
| Medtronic, INC. | $15.72 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.64 | 2024 | |
| Amgen INC. | $15.19 | 2021 | |
| Vanda Pharmaceuticals INC. | $13.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Hattel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.